Vimta Labs Limited Stock

Equities

VIMTALABS

INE579C01029

Biotechnology & Medical Research

Market Closed - Bombay S.E. 06:00:51 2024-05-31 EDT 5-day change 1st Jan Change
475.4 INR +0.01% Intraday chart for Vimta Labs Limited -4.63% +17.72%

Financials

Sales 2022 2.79B 33.42M 45.54M Sales 2023 3.19B 38.25M 52.13M Capitalization 6.95B 83.37M 114M
Net income 2022 413M 4.95M 6.75M Net income 2023 482M 5.78M 7.88M EV / Sales 2022 2.53 x
Net Debt 2022 85.41M 1.02M 1.4M Net cash position 2023 242M 2.9M 3.95M EV / Sales 2023 2.1 x
P/E ratio 2022
17.2 x
P/E ratio 2023
14.7 x
Employees 1,368
Yield 2022
0.63%
Yield 2023
0.64%
Free-Float 30.69%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.01%
1 week-4.63%
1 month-11.41%
3 months-6.99%
6 months+14.18%
Current year+17.72%
More quotes
1 week
465.00
Extreme 465
510.85
1 month
465.00
Extreme 465
538.10
Current year
400.15
Extreme 400.15
600.00
1 year
385.15
Extreme 385.15
621.40
3 years
223.25
Extreme 223.25
621.40
5 years
51.05
Extreme 51.05
621.40
10 years
51.05
Extreme 51.05
621.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 94-12-31
Founder 75 83-12-31
Director of Finance/CFO - 21-02-21
Members of the board TitleAgeSince
Founder 75 83-12-31
Chief Operating Officer 72 83-12-31
Chief Executive Officer 49 94-12-31
More insiders
Date Price Change Volume
24-05-31 475.4 +0.01% 1,457
24-05-30 475.3 -1.26% 4,174
24-05-29 481.4 -1.78% 2,052
24-05-28 490 -3.68% 6,481
24-05-27 508.8 +2.07% 7,170

Delayed Quote Bombay S.E., May 31, 2024 at 06:00 am

More quotes
Vimta Labs Limited is engaged in the business of contract research and testing organization. The Company is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include Drug discovery, development, and drug life cycle management support services; Preclinical research and testing services for medical device companies; Contract research and testing for agrochemical and specialty chemical companies; and Food testing and analytical development services to support manufacturers, processors, farmers, and retailers; Clinical diagnostics services to patients, clinicians, and hospitals, and environmental regulatory services such as impact assessments and post project monitoring, to various industries, such as power and infrastructure.
More about the company
  1. Stock Market
  2. Equities
  3. VIMTALABS Stock